Home > Insider Trading > Filing (0001078782-20-000367)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
93314	Volitionrx Ltd	VNRX	In Vitro & In Vivo Diagnostic Substances (2835)	911949078

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1340610	John Cameron Reynolds	13215 Bee Cave Parkway Suite 125 Galleria Oaks B Austin TX 78738	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-05-22	4,000	$2.75	1,126,273	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	34,076	Indirect	By Wife
Common Stock	1,007,718	Indirect	Concord International, Inc.

Footnotes

The shares were purchased by the reporting person in connection with an underwritten public offering by the Issuer. The offering closed on May 22, 2020. The reported sale price reflects the price at which the reporting person purchased the shares from the underwriter.
The shares of Common Stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of Common Stock held by Concord International, Inc.